US Insurer United Rewards Amgen’s Early Entry With Bevacizumab And Trastuzumab

 
• By Aidan Fry
  
United_Healthcare
Major US health insurer UnitedHealthcare will soon prefer Amgen's becacizumab and trastuzumab biosimilars • Source: Shutterstock

More from Biosimilars

More from Products